Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04561375 · ClinicalTrials.gov registry record · Phase 4
Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery
A Phase 4 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
NCT04561375 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 61 participants.
The verdict
NCT04561375, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
Study Summary
A pilot study to evaluate the effect of incorporating sublingual sufentanil into our perioperative opioid regimen for ambulatory orthopedic surgery.
Interventions
- DRUG Fentanyl
- DRUG Sufentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-12-11 |
| Est. Completion | 2022-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04561375
The ClinicalTrials.gov registry entry for NCT04561375 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fentanyl is the first listed.
NCT04561375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04561375 about?
NCT04561375 is a clinical study titled "Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery". A pilot study to evaluate the effect of incorporating sublingual sufentanil into our perioperative opioid regimen for ambulatory orthopedic surgery.
What is the current status of trial NCT04561375?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2020-12-11. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04561375?
The interventions under investigation include: Fentanyl (DRUG), Sufentanil (DRUG).
Who is sponsoring clinical trial NCT04561375?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.